2023
DOI: 10.1016/j.cbpa.2023.102375
|View full text |Cite
|
Sign up to set email alerts
|

Virus-assisted directed evolution of biomolecules

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

5
3

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 57 publications
0
6
0
Order By: Relevance
“…Viruses provide a distinctive avenue for designing rapid laboratory evolution experiments, capitalizing on their inherent capacity to evolve at a much faster pace than many living organisms [105]. This accelerated evolution is facilitated by their smaller genome size, which tolerates a high frequency of mutations and a rapid rate of replication.…”
Section: Virus-assisted Mutagenesismentioning
confidence: 99%
“…Viruses provide a distinctive avenue for designing rapid laboratory evolution experiments, capitalizing on their inherent capacity to evolve at a much faster pace than many living organisms [105]. This accelerated evolution is facilitated by their smaller genome size, which tolerates a high frequency of mutations and a rapid rate of replication.…”
Section: Virus-assisted Mutagenesismentioning
confidence: 99%
“…Viruses provide a distinctive avenue for designing rapid laboratory evolution experiments, capitalizing on their inherent capacity to evolve at a much faster pace than many living organisms [77]. This accelerated evolution is facilitated by their smaller genome size, which tolerates a high frequency of mutations, and a rapid rate of replication.…”
Section: Virus-assisted Mutagenesismentioning
confidence: 99%
“…Although semi‐rational approaches have been employed with some success to improve the activity of orthogonal suppressor tRNAs in mammalian cells, such approaches are difficult to generalize [6] . Recently, we reported a novel platform for virus‐assisted directed evolution of tRNAs (VADER) in mammalian cells (Figure 1a), which employs a double‐sieve selection scheme to enrich orthogonal tRNA mutants with higher activity from synthetic libraries [2a,d] . The VADER protocol subjects adeno‐associated virus (AAV) particles encoding a suppressor tRNA library to selective replication in mammalian cells.…”
Section: Introductionmentioning
confidence: 99%